Home Print this page Email this page Users Online: 145
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

 Table of Contents  
Year : 2013  |  Volume : 3  |  Issue : 1  |  Page : 39

To the editor

Iranian Center for Endodontic Research, Research Institute of Dental Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Date of Web Publication7-Aug-2013

Correspondence Address:
Saeed Asgary
Iranian Center for Endodontic Research, Research Institute of Dental Sciences, Shahid Beheshti Dental School, Evin, Tehran
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1658-5984.116279

Rights and Permissions

How to cite this article:
Asgary S. To the editor. Saudi Endod J 2013;3:39

How to cite this URL:
Asgary S. To the editor. Saudi Endod J [serial online] 2013 [cited 2023 Feb 1];3:39. Available from: https://www.saudiendodj.com/text.asp?2013/3/1/39/116279


Reviewing and reading the original article "Biocompatibility assessment of modified Portland cement in comparison with MTA ® : In vivo and in vitro studies; Khalil et al. 2012;2:6-13" was highly interesting. The authors presented data from multiple in vitro as well as in vivo studies regarding biocompatibility of a modified Portland cement (MPC) and concluded that "clinical studies should be carried out on MPC before it can be introduced in our clinical practice."

Numerous in vitro studies demonstrated that chemical compounds in both gray/white mineral trioxide aggregate (MTA) and gray/white Portland cement (PC) are similar except the presence of bismuth oxide in MTA. [1],[2] A growing body of evidence suggests that PC could be used clinically as an effective and less expensive MTA alternative; however, the presence of toxic metals such as arsenic and lead in the PC is one of the obstacles to this. Primus strictly stated that according to Food and Drug Administration (FDA) and Conformité Européenne (CE) regulations as well as ethical considerations materials that are manufactured outside of the dental industries should not be used in the clinical practice. [3]

  References Top

1.Asgary S, Parirokh M, Eghbal MJ, Brink F. A comparative study of white mineral trioxide aggregate and white Portland cements using X-ray microanalysis. Aust Endod J 2004;30:89-92.  Back to cited text no. 1
2.Asgary S, Eghbal MJ, Parirokh M, Ghoddusi J, Kheirieh S, Brink F. Comparison of mineral trioxide aggregate's composition with Portland cements and a new endodontic cement. J Endod 2009;35:243-50.  Back to cited text no. 2
3.Primus CM. Comments on "arsenic release provided by MTA and Portland cement" by Duarte MA, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:416-7; author reply 417-8.  Back to cited text no. 3


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article

 Article Access Statistics
    PDF Downloaded268    
    Comments [Add]    

Recommend this journal